AAAAAA

   
Results: 1-11 |
Results: 11
A randomized, placebo-controlled trial of coenzyme Q(10) and remacemide inHuntington's disease
Authors: Kieburtz, K Koroshetz, W McDermott, M Beal, MF Greenamyre, JT Ross, CA Shoulson, I Cudkowicz, ME Sexton, P Skeuse, C Rosas, D Jenkins, B Rosenblatt, A Sherr, M Hersch, S Cellar, J Guttman, M Brown, C Como, PG Marshall, F DeMarcaida, JA Zimmerman, C Marder, K Moskowitz, C Polanco, C Beltre, J Shannon, K Jaglin, JA Niederman, F Ashizawa, T Hunter, C Hunter, C Hauser, R Walker, A Gauger, L Hahn, MA Delgado, H Dawson, T Siemers, E Seeberger, L Dingmann, C Dubinsky, R Gray, C Weiner, WJ Rodriguez-Batemen, D Albin, RL Wernette, K Harrison, M Rost-Ruffner, E Paulsen, J Rodnitzky, RL Dobson, J Vining, L Suchowersky, O Pantella, C Saint-Hilaire, MH Furtado, J Martin, W Wieler, M Walker, F Hunt, V Raymond, L Almqvist, E Rubin, A Blair, B Marek, K Caplan, K Baker, D Brocht, A Casaceli, C Orme, C Rudolph, A Rumfola, L Schifitto, G Shinaman, A Sulimowicz, K Watts, A Eapen, S Zhang, L
Citation: K. Kieburtz et al., A randomized, placebo-controlled trial of coenzyme Q(10) and remacemide inHuntington's disease, NEUROLOGY, 57(3), 2001, pp. 397-404
Effect of neurophilin ligands on motor units in mice with SOD1 ALS mutations
Authors: Shefner, JM Brown, RH Cole, D Chaturvedi, P Schoenfeld, D Pastuszak, K Matthews, R Upton-Rice, M Cudkowicz, ME
Citation: Jm. Shefner et al., Effect of neurophilin ligands on motor units in mice with SOD1 ALS mutations, NEUROLOGY, 57(10), 2001, pp. 1857-1861
Epidemiologic methods in neurology
Authors: Cudkowicz, ME
Citation: Me. Cudkowicz, Epidemiologic methods in neurology, PRINCIPLES OF NEUROEPIDEMIOLOGY, 2001, pp. 1-7
Dynamic markers of altered gait rhythm in amyotrophic lateral sclerosis
Authors: Hausdorff, JM Lertratanakul, A Cudkowicz, ME Peterson, AL Kaliton, D Goldberger, AL
Citation: Jm. Hausdorff et al., Dynamic markers of altered gait rhythm in amyotrophic lateral sclerosis, J APP PHYSL, 88(6), 2000, pp. 2045-2053
Clozapine and risperidone treatment of psychosis in Parkinson's disease
Authors: Ellis, T Cudkowicz, ME Sexton, PM Growdon, JH
Citation: T. Ellis et al., Clozapine and risperidone treatment of psychosis in Parkinson's disease, J NEUROP CL, 12(3), 2000, pp. 364-369
Riluzole therapy in Huntington's disease (HD)
Authors: Rosas, HD Koroshetz, WJ Jenkins, BG Chen, YI Hayden, DL Beal, MF Cudkowicz, ME
Citation: Hd. Rosas et al., Riluzole therapy in Huntington's disease (HD), MOVEMENT D, 14(2), 1999, pp. 326-330
Basic fibroblast growth factor does not prolong survival in a transgenic model of familial amyotrophic lateral sclerosis
Authors: Upton-Rice, MN Cudkowicz, ME Warren, L Mathew, RK Ren, JM Finklestein, SP Brown, RH
Citation: Mn. Upton-rice et al., Basic fibroblast growth factor does not prolong survival in a transgenic model of familial amyotrophic lateral sclerosis, ANN NEUROL, 46(6), 1999, pp. 934-934
Administration of nitric oxide synthase inhibitors does not alter disease course of amyotrophic lateral sclerosis SOD1 mutant transgenic mice
Authors: Upton-Rice, MN Cudkowicz, ME Mathew, RK Brown, RH
Citation: Mn. Upton-rice et al., Administration of nitric oxide synthase inhibitors does not alter disease course of amyotrophic lateral sclerosis SOD1 mutant transgenic mice, ANN NEUROL, 45(3), 1999, pp. 413-414
The pharmacokinetics and pharmacodynamics of Procysteine in amyotrophic lateral sclerosis
Authors: Cudkowicz, ME Sexton, PM Ellis, T Hayden, DL Gwilt, PR Whalen, J Brown, RH
Citation: Me. Cudkowicz et al., The pharmacokinetics and pharmacodynamics of Procysteine in amyotrophic lateral sclerosis, NEUROLOGY, 52(7), 1999, pp. 1492-1494
Cerebrospinal fluid F-2-isoprostanes are elevated in Huntington's disease
Authors: Montine, TJ Beal, MF Robertson, D Cudkowicz, ME Biaggioni, I O'Donnell, H Zackert, WE Roberts, LJ Morrow, JD
Citation: Tj. Montine et al., Cerebrospinal fluid F-2-isoprostanes are elevated in Huntington's disease, NEUROLOGY, 52(5), 1999, pp. 1104-1105
Increased CSF F-2-isoprostane concentration in probable AD
Authors: Montine, TJ Beal, MF Cudkowicz, ME O'Donnell, H Margolin, RA McFarland, L Bachrach, AF Zackert, WE Roberts, LJ Morrow, JD
Citation: Tj. Montine et al., Increased CSF F-2-isoprostane concentration in probable AD, NEUROLOGY, 52(3), 1999, pp. 562-565
Risultati: 1-11 |